Lansap in treatment of esophagitis in patients with systemic sclerosis
Objective. To study the efficacy of Lansap (Lansoprasole) in treatment of esophagitis in pts with systemic sclerosis (SS). Methods. 30 SS pts with clinical manifestations and endoscopic signs of esophagitis received lansap 30 or 60 mg/day during two weeks. All pts had a standard endoscopic examinati...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2003-04-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/901 |